EMCDDA Publishes Its First Report on Health Responses to New Psychoactive Substances
Over the last decade, there has been an unprecedented rise in the number of new drugs appearing on the global market
Join as an individual or organization
In the first long-term follow-up of patients treated with buprenorphine/naloxone (Bp/Nx) for addiction to opioid pain relievers, half reported that they were abstinent from the drugs 18 months after starting the therapy. After 3.5 years...
The aim of this draft discussion paper, “From coercion to cohesion: Treating drug dependence through health care, not punishment”, is to promote a health-oriented approach to drug dependence. The International Drug Control Conventions give...